Shares of Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.01 and traded as low as $0.0087. Evofem Biosciences shares last traded at $0.0092, with a volume of 424,986 shares changing hands.
Evofem Biosciences Trading Down 5.4%
The firm has a market cap of $1.15 million, a PE ratio of -0.01 and a beta of -1.41. The company has a 50 day moving average price of $0.01 and a 200 day moving average price of $0.01.
Evofem Biosciences Company Profile
Evofem Biosciences is a clinical‐stage biotechnology company based in San Diego, California, specializing in women’s sexual and reproductive health. Founded in 2013 as a spin-out of the Scripps Research Institute, the company is focused on developing non-hormonal, on-demand products that address unmet needs in contraception and the prevention of sexually transmitted infections.
The company’s lead commercial product, Phexxi, is an FDA-approved, non-hormonal vaginal gel that maintains the vagina’s natural pH to reduce the risk of unintended pregnancy.
See Also
- Five stocks we like better than Evofem Biosciences
- JPMorgan just admitted to freezing Trump’s bank accounts
- A New Musk Invention Even Bigger Than SpaceX IPO?
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Trump’s NEW Executive Order – BIG Changes Coming to Retirement Accounts
- J.P. Morgan is betting on this coin
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
